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cu.2012.Abstract Prevention of cross contamination with active pharmaceutical ingredient is crucial and
requires special attention in pharmaceutical industry. Current method validation describes residual
determination of olmesartan medoxomil (OLME) on stainless steel surface using swab sampling
with a sensitive HPLC-DAD analysis. The acceptance limit was decided as 2 lg swab pro
100 cm2. Cotton swabs impregnated with extraction solution were used to determine residual drug
content. Recoveries were 95.81%, 93.06%, and 96%. 24% with RSD below 1.5% at three concen-
tration levels. Residual concentration was found to be linear in the range of 0.557–5.62 lg/mL,
when estimated using Phenomenex Luna C18 (25 cm · 5 lm · 4.6 mm i.d.) column at 1.0 mL/min
ﬂow rate at 258 nm. The mobile phase consisted of a mixture of acetonitrile: methanol: phosphate
buffer pH 3.5: tetrahydrofuran (28:13:58:1 v/v/v/v). The LOD and LOQ for OLME were found to
be 0.07 and 0.22 lg/mL, respectively. The validated method was found to be simple, selective and
sensitive for demonstration of cleaning validation of OLME residues on the stainless steel surface.
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11.0041. Introduction
Cleaning validation is a critical analytical responsibility of
quality assurance system in pharmaceutical industry. Cleaning
validation must be demonstrated as per current GMP norms.
Residues have a signiﬁcant cross contamination potential.
Residual estimation requires development of selective and sen-
sitive methods capable of quantitative estimation of traceshosting by Elsevier B.V.Open access under CC BY-NC-ND license.
96 N. Dubey et al.remaining over the surface of manufacturing equipments after
cleaning procedure. It involves identiﬁcation of numerous
sampling points in the manufacturing lane to demonstrate a
complete removal of residues. Currently acceptance limits for
residues are not advised by regulatory agencies, but decision
is based on the logical criteria such as risk associated with
the quality or safety of ﬁnished product.
Generally the limit for maximum accepted residue of active
ingredient (maximum allowable carryover, MACO) is based
on mathematical formulae, therapeutic doses, and toxicologi-
cal proﬁle and kept at general limit of 10 ppm.1–4 Several ap-
proaches to express acceptance limits have been proposed in
the published scientiﬁc work. One approach is to compare vi-
sual limit of detection (VLOD) with pharmacology based cri-
teria, where not more than 1/1000th of the therapeutic dose
of active component should be carried over to the next batch
as residue, lower of the two is considered as residual accep-
tance criterion. Other approach involves estimating a total
amount of allowable residue present on production line, which
is termed as residual acceptance level (RAL). Further, concen-
tration of residue present per unit equipment surface area may
be computed, which is termed as speciﬁc residual cleaning level
(SRCL) or limit per surface area (LSA).
Olmesartan, the medoxomil salt of (5-Methyl-2-oxo-1,3-
dioxol-4-yl) methyl ester of 4-(1-hydroxy-1-methylethyl)-2-
propyl-1-{[20-(1H-tetrazol-5-yl)[1,10-biphenyl]-4-yl]methyl}-1H-
imidazole-5-carboxylic acid, is the ester prodrug of a new gen-
eration of effective and orally active angiotensin-II receptor
antagonist (Fig. 1). It blocks the vasoconstrictor and aldoste-
rone-secreting effects of angiotensin-II, one of the most impor-
tant regulators of blood pressure.5,6 The determination of
OLME from tablet formulation has been carried out by
HPLC, HPTLC and spectrophotometrically, alone or in com-
bination. Several analytical methods have been reported for
their determination alone or in combination with other drugs
in different dosage forms, biological ﬂuids and urine using dif-
ferent analytical techniques.7–9 Available literature revealed
that no method related to residual determination of OLME
was reported so far, hence it was found worthwhile to deter-
mine LSA of OLME and to carry out the development and
validation of the method in order to ensure trace level estima-
tion of residues and to demonstrate efﬁciency of the cleaning
procedure.Figure 1 Structural formula of olmesartan medoxomil.2. Materials and Methods
2.1. Reagent and chemicals
OLME reference standard (USP) was obtained from Cipla
Ltd., Mumbai as gratis sample. Olmecip (OLME, 40 mg)
and Olmesafe (OLME, 20 mg) tablets were procured from
manufacturer. HPLC grade water was prepared by taking re-
verse osmosis water and passing it through a Milli-Q System
(Millipore, Milford, USA). Alpha Swab polyester on a propyl-
ene handle-TX714A (ITW Tex wipe, USA) was used for
extraction recovery sampling. Chemicals such as acetonitrile,
methanol, isopropyl alcohol, sodium phosphate, sodium cit-
rate, dibasic potassium phosphate and citric acid were ob-
tained from Merck, Germany. All other chemicals used were
of analytical reagent grade.
2.2. Chromatographic system and conditions
The LC system consisted of (Shimadzu LC 10AT VP) gradient
pump with universal loop injector (Rheodyne 7725i) of 20 lL
injection capacity, photodiode array detector (PDA) SPD-10
AVP and Phenomenex Luna C18 (25 cm · 5 lm · 4.6 mm
i.d.) column at 1.0 mL/min ﬂow rate using 20 lL injection vol-
ume controlled by a PC work station equipped with software
CLASS-Vp (software M-10, version 1.6) (Shimadzu, Tokyo,
Japan). Column temperature was ambient. The mobile phase
consisted of a mixture of 28 mL acetonitrile, 13 mL methanol,
58 mL phosphate buffer (pH 3.5 ± 0.2, prepared by mixing
0.2 M sodium phosphate solution and 0.1 M citric acid solu-
tion at ratio of 30:70 v/v) and 1 mL tetrahydrofuran
(28:13:58:1 v/v/v/v). The mobile phase solution was ﬁltered
through 0.45 lm membrane ﬁlter (Millipore) and degassed
prior to use. Extraction solution consisted of 50 mL mobile
phase solution, 20 mL IPA and 30 mL water (50:20:30 v/v/
v). All chromatographic experiments were performed in iso-
cratic mode. UV detection was performed at 258 nm. The
method was validated as per ICH guidelines. The statistical
analysis was performed using Microsoft Excel 2007.
2.3. Standard solution preparation
The stock solution of standard was prepared by accurately
weighing OLME reference standard and transferred into a
50 mL volumetric ﬂask. Twenty milliliter of methanol was
added and the content of ﬂask was sonicated for 30 min. The
solution was appropriately diluted with the mobile phase to
get the ﬁnal concentration of 0.020 mg/mL. A series of calibra-
tion standards were prepared by transferring appropriate ali-
quots of standard OLME solutions into separate 100 mL
volumetric ﬂasks to get dilutions.
2.4. Sample solution preparation
10 cm · 10 cm of stainless steel surface appropriately cleaned
and dried, was sprayed with 250 lL of standard stock solution,
for the positive swab control at all concentration levels, and
the solvent was allowed to evaporate. The surface was wiped
using a wet cotton swab soaked with extraction solution (mo-
bile phase: IPA: water, 50:20:30 v/v/v). The swab was squeezed
into the swab tube as per the procedure mentioned in Section
2.5. The background control sample was prepared from the
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similarly. Care was taken to avoid contact of swab with the
test surface. Subsequently, the tubes were placed in an ultra-
sonic bath for 15 min and the solutions were analyzed by
HPLC-DAD.
2.5. Swab wipes sampling protocol
Rinse and swab are two sampling methods available to demon-
strate cleaning validation. Swab technique is a preferred tech-
nique by the United States Food and Drug Administration.
1,10,11 The swabbing process is a subjective manual process that
involves physical interaction between the swab and the surface,
and thus may vary from operator to operator.12–15 So, a stan-
dardized motion protocol is required to establish reproducible
recoveries. A patch of 4 · 4 inch swab was immersed in extrac-
tion solution and folded diagonally. Excess solution was
squeezed to avoid unnecessary dilution of drug. Folded swab
was kept between the thumb and second ﬁnger, so that neces-
sary force may be applied over the surface through the ﬁrst ﬁn-
ger. The surface was wiped horizontally, starting from outside
toward the center. Fresh surface was exposed and repeatedly
wiped to extract the maximum residue. Finally the swab was
secured in a closed and labeled container for estimation.
3. Results and discussion
3.1. Acceptance limit calculation
Cleaning validation of production lane is one of the most crit-
ically controlled tasks. Visual as well as analytical observationsFigure 2 Chromatograms obtained from (a) olmesartan medoxom
40 ppm, (c) non-spiked stainless steel, (d) excipient mixture, (e) ratio
ratio chromatogram of olmesartan medoxomil standard solution.help to achieve the goal. Considering SRCL, VLOD, MACO
and stainless steel surface area of 10 cm · 10 cm, the calculated
limit per surface area (LSA) was decided as 2 lg swab pro
100 cm2.
3.2. Optimization of the chromatographic conditions
Best chromatographic conditions were achieved by optimizing
the wavelength for detection, mobile phase composition and
ﬂow rate. The mobile phase consisted of a mixture of 28 mL
acetonitrile, 13 mL methanol, 58 mL phosphate buffer
(pH 3.5 ± 0.2 adjusted with o-phosphoric acid) and 1 mL tet-
rahydrofuran (28:13:58:1% v/v/v/v). Two-hundred and ﬁfty
eight nanometers was selected as detection wavelength as cali-
bration curve showed good linearity and trace level estimations
were possible. The above optimized chromatographic condi-
tions are results of efforts to achieve appropriate plate num-
bers, peak symmetry, resolution and tailing factor.
3.3. Optimization of the sample treatment
Cotton swabs were spiked with different quantities of the drug
and placed into tubes. The optimum conditions were achieved
with the mobile phase: Isopropyl alcohol: water (50:20:30% v/
v/v) as the extracting solvent and soniﬁcation time for 15 min.
3.4. Validation of the method
The main objective was to develop an HPLC-DAD method for
estimation of residues collected by swabs, without interference
of impurities originating from the swabs, plates and extractionil standard solution, 20 ppm, (b) olmesartan medoxomil sample,
chromatogram of olmesartan medoxomil sample solution and (f)
Table 1 Linear regression data in the analysis of OLME.
Statistical parameters Values
Concentration range (lg/mL) 0.557–5.623
Regression equation y= 116.99x+ 14.619
Coeﬃcient of determination r2 = 0.9997
Residual standard deviation 3.85
Table 2 Precision and accuracy of the results obtained from
swabbed plates spiked with OLME.
Cons. added
(lg/mL)
Cons. found
(lg/mL)
95% conﬁdence
interval (%)
%Recovery
(RSD, n= 6)
1.91 1.83 94.2–95.81 95.81 ± 0.81
4.18 3.89 93.47–94.66 93.06 ± 1.4
5.86 5.64 97.54–95.37 96.24 ± 0.63
98 N. Dubey et al.media. The method was validated for linearity, precision, limit
of detection, limit of quantiﬁcation, accuracy, selectivity, and
stability of analyte.15–17
3.4.1. System suitability
The average number of theoretical plates per column was
>3400, the USP tailing factor <1.2 and the resolution
>2.0. Relative standard deviation (RSD) of the peak areas
was <2.0%.
3.4.2. Speciﬁcity
The speciﬁcity of the method was checked by using standard,
sample, background control sample, negative swab control,
swabbed un-spiked stainless steel plate (Fig. 2) and four stan-
dard solutions after storage under destructive condition at
75 C, acid, base and H2O2 for 24 h. Chromatographic resolu-
tion of more than 1.5 was achieved for OLME from unknown
peaks (Fig. 2).Table 3 Effect of different chromatographic parameters over meth
No. Parameters Cons. (lg/mL) RSDa
1. Wavelength (nm)
254 0.832 0.69
256 0.835 0.14
258 0.832 0.11
260 0.832 0.83
262 0.834 1.05
2. Mobile phase compositionb
27:13:56:2 0.831 1.12
27:13:59:1 0.834 0.34
30:13:56:1 0.832 0.63
29:11:59:1 0.832 0.92
26:13:60:1 0.836 0.45
3. Flow rate (mL/min)
0.8 0.832 0.54
0.9 0.837 0.66
1.0 0.834 0.32
1.1 0.823 0.92
1.2 0.827 1.32
a RSD (%).
b Mobile phase composition shown as acetonitrile, methanol, phosphat3.4.3. Linearity
Standard solutions were analyzed at six different concentration
levels ranging from 0.557 to 5.62 lg/mL, with six determina-
tions at each level. Linearity was observed when mean re-
sponse area was plotted against concentration using the least
square regression method (Table 1).
3.4.4. Limit of detection (LOD) and limit of quantiﬁcation
(LOQ)
LOD and LOQ were determined on the basis of standard devi-
ation of the response (y-intercept) and the slope of the calibra-
tion curve at low concentration levels according to ICH
guidelines.18–20 The LOD and LOQ for OLME were found
to be 0.07 and 0.22 lg/mL, respectively.
3.4.5. Precision and accuracy
Recovery is the percentage of residualmaterial that is actually re-
moved by the sampling technique. Concentration of analyte was
compared with spiked sample at three different concentration
levels, six replicates each (1.91, 4.18 and 5.86 lg/mL). Observa-
tions are reported (Table 2) as relative standard deviation (RSD)
and the recovery (%). Observations demonstrate appropriate-
ness of method for the purpose of residue monitoring.
Six consecutive injections of standard solutions on two dif-
ferent days by different analysts and different reagents were
performed to evaluate the intermediate precision of the meth-
od and expressed as the RSD. The %RSD was found to be
1.85% and 1.92% for the ﬁrst and second days, respectively.
The observations indicate acceptable inter-mediate precision
for OLME solution.
3.4.6. Robustness
Robustness of the HPLC-DAD method was demonstrated by
evaluation of the effect of different chromatographic parame-
ters on the resolution and the concentration of OLME samples
(Table 3). The ﬂow rate was varied from 0.5 mL/min to
1.5 mL/min. The concentration of buffer in the mobile wasod performance.
Tailing factor Resolution Plate count
1.18 2.56 3532
1.20 2.44 3545
1.20 2.56 3624
1.18 2.45 3580
1.20 2.56 3573
1.18 2.11 3360
1.23 2.46 3450
1.22 2.52 3521
1.18 2.52 3312
1.22 2.48 3543
1.20 2.50 3455
1.20 2.56 3461
1.20 2.50 3578
1.18 2.32 3343
1.18 2.21 3211
e buffer pH 3.5, tetrahydrofuran (v/v/v/v).
Table 4 Estimation of OLME in actual swab samples
(100 cm2 swabbed area) from different sampling points on
production lane.
No. Sampling point Residual cons. (lg/mL)
1. Upper hopper BDL
2. Lower hopper BDL
3. Lower connecting sleeve 0.24
4. Tablet collector 0.668
5. Die 0.332
6. Punch 0.362
7. Trunion 0.235
8. Lid gasket 0.324
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258 ± 4 nm. Signiﬁcant differences were not observed in chro-
matographic parameters.
3.4.7. Sample and standard stability
The stability of the OLME in the swab matrix and OLME stan-
dard solution, was tested by storing them at ambient tempera-
ture for 24 h. They were injected after 6 h, 12 h and 24 h against
fresh standard solutions. The stability of the standard OLME
solution (6.2 lg/mL) and samples solutions after 24 h showed
2.73% difference in results. The stability of OLME in swab ma-
trix showed 2.01% difference in results. Chromatography of
both the samples showed no additional peaks (Fig. 2).
3.4.8. Filter evaluation
Samples and standard solutions of OLME, were ﬁltered with
Millipore millex – HV-PVDF 0.45 lm and millex – PTFE-
0.45 lm, and compared with unﬁltered samples. The Millipore
millex – HV-PVDF 0.45 lm and millex – PTFE-0.45 lm pore
size syringe ﬁlters were qualiﬁed for use with a ﬁlter evaluation
ratio of 100.23% and 100.32% for OLME standard solution
with PVDF and PTFE ﬁlter, respectively. For samples the ﬁl-
ter evaluation ratio was 100.18% and 101.14% for PVDF and
PTFE ﬁlter respectively.
3.5. Estimation of OLME in swab samples collected from
production lane
Various samples were collected from different sampling points
over the production lane. Samples were tested for residual con-
tent of OLME. Partial data are shown in Table 4.
4. Conclusion
A validated, selective and simple HPLC-DAD method was
developed for residual determination of OLME to demonstrate
cleaning validation on stainless steel surfaces of the production
lane. Method with appropriate swab wipe procedure was found
to be precise, accurate and linear. No interference from swab
solution was observed and samples were stable for 24 h.5. Conﬂict of interest
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